This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          April 30, 2015

Home  |   About SCAI  |   Membership  |   Education  |   Quality  |   Advocacy  |   Careers & Fellows  |   Press  |   Contact Us

 



In this issue...




SCAI NEWS

Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelets as Prescribed
SCAI
People with acute coronary syndrome (ACS) who undergo an angioplasty procedure and receive a heart stent are prescribed an oral antiplatelet (OAP) therapy and aspirin to help prevent a heart attack, a blood clot in their heart stent (stent thrombosis) or even death. Yet, a recent survey conducted by Harris Poll found that 52 percent of 275 ACS patients who were currently taking an OAP have missed taking or changed the way they take their prescribed OAP therapy, even though most of them were informed by their doctors of the importance of the therapy to their heart health. Of these respondents, those under age 65 (194 participants) were much more likely not to follow their OAP therapy regimen as prescribed than older respondents, even though they were more concerned about their health, according to the survey findings.

To address this critical issue, SCAI, the Preventive Cardiovascular Nurses Association (PCNA) and Mended Hearts, with support from Daiichi Sankyo Inc. and Eli Lilly and Company, are introducing the "After the Stent: Follow Your Action Plan™" campaign. The campaign aims to mobilize cardiovascular healthcare professionals to improve ACS patients' knowledge and practices related to OAP adherence. Learn more about this campaign.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  


Shining a Spotlight on the Latest in Ischemic CAD Management at SCAI 2015
SCAI

The treatment of patients with complex coronary artery disease (CAD), such as multi-vessel disease and chronic total occlusions, has become increasingly common. However, important questions still remain, including where the interventionalist's territory ends and the surgeon's begins, and vice versa. A special session on the topic at SCAI 2015 will feature experience and expertise from diverse faculty members who have helped generate the evidence-based data for ischemic CAD management, according to Ehtisham Mahmud, MD, FSCAI. The session will also look beyond the data and examine the importance of incorporating the patient's choice into the decision-making process. Learn more.

Related:

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Global Interventional Medical Devices
Whether you are a healthcare professional, a patient or simply someone looking to know more about the complete solutions offered by Cordis, let us show you how our distinctive approach to working in partnership with you results in innovative interventional products and services to help support sustained patient outcomes.

SCAI Show Booth #218
 


SCAI Women in Innovations Symposium to Let Fellows Test Their Skills With the Experts
SCAI
Some of the best and brightest interventional cardiology fellows-in-training from across the country will be in the spotlight during SCAI 2015 during a lunch symposium on Thursday, May 7.

"Complex Coronary Interventions: Coast to Coast," will showcase these FITs presenting complex coronary and structural cases to an expert panel for their review and unbiased feedback. Presenters include Vivian Ng, MD, of Yale University, Kusum Lata, MD, of University of Arizona Medical Center, Satish Chandraprakasam, MD, of Alegant Creighton Heart & Vascular Institute and Shiny Mathewkutty, MD, of Mount Sinai School of Medicine. SCAI-WIN Chair Cindy Grines, MD, FSCAI, will serve as moderator, and the expert panelists are Amir Kaki, MD, FSCAI, Ruby Satpathy, MD, FSCAI, Kimberly Skelding, MD, FSCAI, Roxana Mehran, MD, FSCAI, and Paul Teirstein, MD, FSCAI. Show your support! Enroll for the SCAI-WIN Symposium.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACE to Present Data Supporting the Value of Cath Lab Accreditation at SCAI 2015
SCAI
Accreditation for Cardiovascular Excellence (ACE) will release new data at SCAI 2015, providing cardiac cath lab stakeholders with quality metrics confirming the value of ACE Accreditation. In a series of three studies, Bonnie H. Weiner, MD, MBA, MSCAI, and colleagues examined multiple quality, performance and outcome measures among 24 facilities that have achieved full ACE accreditation for their diagnostic cardiac catheterization and percutaneous coronary intervention (Cath/PCI) programs with facilities that did not meet the rigorous standards for ACE accreditation.

"We found that ACE-accredited cardiac cath labs were significantly more likely than nonaccredited facilities to meet the highest-quality standards for more than a dozen structural, process-related and procedural domains. These data clarify and support the critical role of ACE accreditation in assisting facilities to provide excellent cardiovascular care," said Dr. Weiner, ACE's chief medical officer. Learn more about this data to be presented at SCAI 2015.

Related:

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Join the #SCAI2015 Dialogue on Twitter
SCAI
New to Twitter? This is the perfect opportunity to join and connect with others on a commonly shared interest.

Not sure what you should share on Twitter? Here are a few ideas:
  • Tell us which sessions and workshops you're attending.
  • Share interesting and helpful takeaways from sessions.
  • Share links to online resources that other attendees might also find useful.
  • Post photos from the sessions, exhibit halls or other social gatherings of you and your colleagues.
  • Share news stories about the conference or other relevant topics.
Learn more — from basics (what is a hashtag?) to more advanced (70-20-10 plan) — by visiting the #SCAI2015 Twitter Guide.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Image of the Week: Respect the Profunda Femoris
SCAI

Anand Prasad, MD, FSCAI, and Yazan Ghosheh, MD, of UT Health Science Center San Antonio, review an interesting case of a patient presenting with calf, thigh and buttocks claudication with disease of the profunda femoris artery, an artery interventionalists rarely treat. Follow this case as it covers eight months.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


INDUSTRY NEWS


Structured Reporting: The Road Map for Better Data, Workflow and Reports
Cardiovascular Business
Creating the structured cardiac cath lab procedure report is the first step to improving patient care and data accuracy, coordinating intraprocedure workflow across the clinical team, making registry reporting seamless and reducing overall cost of care. With just 10 percent of U.S. cath labs utilizing structured reporting today, it is time to spread the word, says James E. Tcheng, MD, FSCAI, who is vice-chair and co-author of the ACC/AHA/SCAI 2014 Health Policy Statement on Structured Reporting for the Cardiac Catheterization Laboratory that came out last year and has been gaining attention ever since.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ISAR-TRIPLE Published: No Net Gain for 6 Weeks Versus 6 Months of Triple Therapy
Cardiovascular Research Foundation
For patients on an oral anticoagulant and aspirin, the addition of clopidogrel for six weeks after stent implantation offers no net clinical benefit over six months of triple therapy, according to the ISAR-TRIPLE trial published in the April 28 issue of the Journal of the American College of Cardiology.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PCSK9 Inhibitors Appear to Lower Death Risk
MedPage Today
Treatment with cholesterol-lowering PCSK9 inhibitors was associated with a reduced risk of death from all causes and a reduction in cardiovascular deaths in a meta-analysis involving more than 10,000 patients. Compared with statin-treated patients who also received a placebo or the drug ezetimibe (Zetia), PCSK9 inhibitor-treated patients had lower all-cause mortality and cardiovascular mortality, researcher Eliano Navarese, MD, PhD, of Heinrich Heine University, Dusseldorf, Germany, and colleagues, wrote in Annals of Internal Medicine, published online ahead of print April 27.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Undetected Diabetes Common in Heart Attack Patients
HealthDay News via Renal & Urology News
One in 10 acute myocardial infarction patients without a previous diagnosis of diabetes mellitus have underlying diabetes mellitus, according to research published online in Circulation: Cardiovascular Quality and Outcomes. Suzanne V. Arnold, MD, MHA, from Saint Luke's Mid America Heart Institute in Kansas City, Missouri, and colleagues reported on the incidence of new diabetes mellitus and its recognition among patients with acute myocardial infarction.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Cilostazol May Improve Freedom From Amputation After Lower-extremity Revascularization
Healio
Use of cilostazol after lower-extremity revascularization was associated with improved amputation-free survival at one year in a cohort of patients aged 65 years and older. Researchers investigated potential associations between cilostazol use and limb salvage in 22,954 older patients undergoing endovascular or open surgery for lower-extremity revascularization from 2007 to 2008.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Registry Finds No Stark Differences Between Proximal, Distal Embolic Protection in CAS
Cardiovascular Research Foundation
Fewer than 1 in 15 U.S. patients undergoing elective carotid artery stenting are treated using proximal rather than distal embolic protection, according to a registry study published in the April issue of JACC: Cardiovascular Interventions. However, both types of embolic protection devices carry similarly low rates of in-hospital and 30-day outcomes.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


COPD Tied to Elevated Risk for Sudden Cardiac Death
Medscape
Individuals with chronic obstructive pulmonary disease have a 34% increased risk for sudden cardiac death compared with healthy age- and sex-matched adults, according to new research from the Rotterdam Study. More than five years after COPD diagnosis, SCD risk almost doubles, and in patients with frequent exacerbations, the risk rises more than threefold, Lies Lahousse, PhD, a postdoctoral researcher in respiratory medicine at Ghent University Hospital in Belgium, and colleagues report in an article published online April 28 in the European Heart Journal.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


'Motion-tracking' MRI Tests Reveal Novel Harbingers of Stroke in People With Common Heart Rhythm Disorder
Health Canal
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ONLINE JOB BOARD

Job Title Employer Location
Clinical Supervisor UHS of Delaware Inc. Wildomar, CA
Physician Assistant - Cardiology St. Peter's Health Partners Saratoga Springs, NY
Registered Nurse - Cath Lab CHSPSC LLC Warren, OH

For a complete list of job postings, click here
To post your resume, click here


CALENDAR OF EVENTS

Date Event Location
May 6 SCAI Vascular Access Safety Course San Diego
May 6-9 SCAI 2015 Scientific Sessions San Diego
May 8 Cath Lab Leadership Boot Camp at SCAI 2015 San Diego
May 8 C3 SUMMIT® for Fellows at SCAI 2015 San Diego
August 22-23 SCAI China Fellows Course TBA
Dec. 6-9 SCAI 2015 Fall Fellows Courses Las Vegas



The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI. The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at scai@multibriefs.com.


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Medscape Cardiologist Compensation Report 2015 (Medscape)
Best Degree of Oversizing Varies by TAVR Device (Cardiovascular Research Foundation)
Radial RIVALs Femoral Access, Especially in Women (Cardiovascular Research Foundation)
Hydration During PCI Reduces Contrast Nephropathy (HealthDay News via Renal & Urology News)

Don't be left behind. Click here to see what else you missed.


 



SCAI This Week
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Katina Smallwoood, Senior Content Editor, 469.420.2675 
Contribute news

Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of SCAI This Week was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

April 23, 2015
April 16, 2015
April 9, 2015
April 2, 2015






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063